BONEH — BBS-Bioactive Bone Substitutes Oyj Income Statement
0.000.00%
Last trade - 00:00- €1.51m
- €6.24m
Annual income statement for BBS-Bioactive Bone Substitutes Oyj, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | FAS | FAS | FAS | FAS | FAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | |||||
| Gross Profit | -0.106 | -0.083 | -0.057 | -0.03 | -0.004 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 1.54 | 2.65 | 2.57 | 2.95 | 3.37 |
| Operating Profit | -1.54 | -2.65 | -2.57 | -2.95 | -3.37 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -1.64 | -2.73 | -2.77 | -3.09 | -3.48 |
| Net Income After Taxes | -1.64 | -2.73 | -2.77 | -3.09 | -3.48 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -1.64 | -2.73 | -2.77 | -3.09 | -3.48 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -1.64 | -2.73 | -2.77 | -3.09 | -3.48 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.21 | -0.307 | -0.309 | -0.297 | -0.272 |
| Dividends per Share |